ANVS

AS OF

Nov 13, 04:59 PM (EDT)

Price

$2.31

Change

-$0.12 (-4.94%)

Capitalization

63.46M

130 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ANVS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Annovis Bio (ANVS) Earnings Date & Reports

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANVS is expected to report earnings to fall 16.22% to -31 cents per share on March 23

Q4'25

Est.

$-0.31

Q3'25

Missed

by $0.06

Q2'25

Beat

by $0.08

Q1'25

Beat

by $0.06

Q4'24

Missed

by $0.11

The last earnings report on November 12 showed earnings per share of -37 cents, missing the estimate of -31 cents. With 382.94K shares outstanding, the current market capitalization sits at 63.46M.

View a ticker or compare two or three

Compare

ANVS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANVS showed earnings on November 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ANVS

A.I. Advisor

published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

101 Lindenwood Drive

Phone

+1 484 875-3192

Employees

Web

https://www.annovisbio.com